Results 231 to 240 of about 9,802 (262)

Bisphosphonate-associated osteonecrosis of the jaws

Journal of Oral and Maxillofacial Surgery, 2005
MICHAEL R. MARKIEWICZ, JOSEPH E. MARGARONE, JOHN H. CAMPBELL, ALFREDO AGUIRRE   +3 more
openaire   +3 more sources

Clinical aspects and management of bisphosphonates-associated osteonecrosis of the jaws

Acta Odontologica Scandinavica, 2006
An increasing incidence of osteonecrosis of the jaws (ONJ) in patients treated with intravenous bisphosphonates has been reported in the literature. The aim of this study was to evaluate the clinical aspects, diagnostic investigations, and management of ONJ associated with bisphosphonates in a series of 12 patients.Our patients included 1 asymptomatic ...
BIASOTTO, MATTEO, CHIANDUSSI S, DORE F, RINALDI A, RIZZARDI, CLARA, CAVALLI F, DI LENARDA, Roberto   +6 more
openaire   +3 more sources

Consequence of therapy discontinuation in bisphosphonate-associated osteonecrosis of the jaws

British Journal of Oral and Maxillofacial Surgery, 2009
We report a patient with bisphosphonate-associated osteonecrosis of the jaws who developed pathological fractures of the upper and lower extremities after the suspension of treatment with bisphosphonates. Temporary discontinuation of the drugs does not alter the clinical course of the disease, and could result in the recurrence of bone pain and the ...
Lorena, Gallego, Luis, Junquera
openaire   +2 more sources

[Bisphosphonate-associated osteonecrosis of the jaws 1].

Nederlands tijdschrift voor tandheelkunde, 2007
Bisphosphonates are generally administered either orally or intravenously. Orally administered bisphosphonates are primarilly used in the treatment of postmenopausal osteoporosis, glucocorticoid-induced osteoporosis, and Paget's disease. When orally administered, only about 1% is absorbed from the tractus from the tractus digestivus.
R H B, Allard, P, Lips, E M W, Eekhoff, J P R, van Merkesteyn, I, van der Waal   +4 more
openaire   +1 more source

Panoramic radiograph, computed tomography or magnetic resonance imaging. Which imaging technique should be preferred in bisphosphonate-associated osteonecrosis of the jaw? A prospective clinical study

Clinical Oral Investigations, 2010
P. Stockmann, F. Hinkmann, M. Lell, M. Fenner, E. Vairaktaris, F. Neukam, E. Nkenke   +6 more
semanticscholar   +1 more source

Osteotomy and primary wound closure in bisphosphonate-associated osteonecrosis of the jaw: a prospective clinical study with 12 months follow-up

Supportive Care in Cancer, 2010
P. Stockmann, E. Vairaktaris, F. Wehrhan, M. Seiss, S. Schwarz, B. Spriewald, F. Neukam, E. Nkenke   +7 more
semanticscholar   +1 more source

Is bisphosphonate-associated osteonecrosis of the jaw caused by soft tissue toxicity?

Bone, 2007
I. Reid, M. Bolland, A. Grey
semanticscholar   +1 more source

Nd:YAG Laser Biostimulation in the Treatment of Bisphosphonate-Associated Osteonecrosis of the Jaw: Clinical Experience in 28 Cases

Photomedicine and Laser Surgery, 2008
P. Vescovi, E. Merigo, M. Manfredi, M. Meleti, C. Fornaini, M. Bonanini, J. Rocca, Samir Nammour   +7 more
semanticscholar   +1 more source

Saliva diagnostics in patients suffering from bisphosphonate-associated osteonecrosis of the jaw: Results of an observational study.

Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery, 2020
P. Stockmann, T. Ebker, Jasmin Bergauer, F. Wehrhan   +3 more
semanticscholar   +1 more source

Prevalence and risk factors of bisphosphonate-associated osteonecrosis of the jaw in prostate cancer patients with advanced disease treated with zoledronate.

European Urology, 2008
C. Walter, B. Al‐Nawas, K. Grötz, Christian Thomas, J. Thüroff, V. Zinser, H. Gamm, J. Beck, W. Wagner   +8 more
semanticscholar   +1 more source